Levaquin and Juluca drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Levaquin (levofloxacin) and Juluca (dolutegravir sodium; rilpivirine hydrochloride). Common drug interactions include chronic kidney disease among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Levaquin and Juluca. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Levaquin?
Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.
What is Juluca?
Juluca has active ingredients of dolutegravir sodium; rilpivirine hydrochloride. eHealthMe is studying from 1,732 Juluca users. Check the latest studies of Juluca.
12 people who take Levaquin and Juluca together, and have interactions are studied.

What are the common drug interactions of Levaquin and Juluca, by gender? *:
female:
- Chronic kidney disease
- Emotional distress
- Pain
- Anaemia (lack of blood)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Foot deformity (functional disability of foot)
- Foot fracture
- Gait disturbance
- Glomerulosclerosis (a hardening of the glomerulus in the kidney)
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Blood urine present
- Bone density decreased
- Decreased activity
- Fear
- Gait disturbance
- Injury
- Nerve injury
- Osteopenia (a condition where bone mineral density is lower than normal)
What are the common drug interactions of Levaquin and Juluca, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Back pain
- Blood urine present
- Decreased activity
- Depression
- Emotional distress
- Fear
- Osteopenia (a condition where bone mineral density is lower than normal)
- Pain
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chest pain
- Chronic kidney disease
- Emotional distress
- Headache (pain in head)
- Pain
50-59:
- Chronic kidney disease
- Emotional distress
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Osteoporosis (bones weak and more likely to break)
- Glomerulosclerosis (a hardening of the glomerulus in the kidney)
- Renal disorder (kidney disease)
- Renal failure (kidney dysfunction)
- Bone density decreased
60+:
- Chronic kidney disease
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Renal impairment (severely reduced kidney function)
- Renal failure (kidney dysfunction)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Arteriovenous fistula site complication
- Emotional distress
- Gait disturbance
- Injury
What are the existing conditions these people have? *
- Hiv Infection: 12 people, 100.00%
- Viral Infection: 2 people, 16.67%
- Quit Smoking: 2 people, 16.67%
- Pain: 2 people, 16.67%
- Overdose: 2 people, 16.67%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 16.67%
- Menopause (end of monthly cycles in women): 2 people, 16.67%
- Inflammation: 2 people, 16.67%
- Hypersensitivity: 2 people, 16.67%
- High Blood Pressure: 2 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Levaquin and Juluca?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Levaquin and Juluca:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levaquin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Juluca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levaquin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Juluca and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levofloxacin and dolutegravir sodium; rilpivirine hydrochloride (the active ingredients of Levaquin and Juluca, respectively), and Levaquin and Juluca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Motrin cause Blood Parathyroid Hormone Decreased? - 8 seconds ago
- Gastroesophageal Reflux Disease and Insomnia - 15 seconds ago
- Drug interactions of Toprol-Xl and Mercaptopurine - 46 seconds ago
- Drug interactions of Hydramine and Succinylcholine Chloride - 56 seconds ago
- Drug interactions of Vfend and Cytoxan - a minute ago
- Drug interactions of Invega Sustenna and Ziprasidone Mesylate - a minute ago
- Lung Disorder and Anxiety Aggravated - a minute ago
- Drug interactions of Atropine Sulfate and Astelin - a minute ago
- Could Metoprolol Tartrate cause Vasodilatation? - a minute ago
- Drug interactions of Cozaar and Duopa - 2 minutes ago